S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
Log in
NASDAQ:CHRS

Coherus BioSciences News Headlines

$15.83
+0.59 (+3.87 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$14.77
Now: $15.83
$15.86
50-Day Range
$15.25
MA: $17.76
$21.39
52-Week Range
$10.86
Now: $15.83
$22.22
Volume2.14 million shs
Average Volume1.56 million shs
Market Capitalization$1.15 billion
P/E Ratio7.76
Dividend YieldN/A
Beta1.57

Headlines

Coherus BioSciences (NASDAQ CHRS) News Headlines Today

Source:
SourceHeadline
Citigroup Lowers Coherus BioSciences (NASDAQ:CHRS) Price Target to $27.00Citigroup Lowers Coherus BioSciences (NASDAQ:CHRS) Price Target to $27.00
marketbeat.com - February 25 at 2:41 PM
Coherus announces start of rolling submission of Toripalimab marketing applicationCoherus announces start of rolling submission of Toripalimab marketing application
seekingalpha.com - March 5 at 8:01 AM
Coherus BioSciences (NASDAQ:CHRS) Price Target Lowered to $29.00 at HC WainwrightCoherus BioSciences (NASDAQ:CHRS) Price Target Lowered to $29.00 at HC Wainwright
americanbankingnews.com - March 3 at 10:51 AM
Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal CarcinomaJunshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma
finance.yahoo.com - March 3 at 9:30 AM
Coherus BioSciences (NASDAQ:CHRS) Trading Up 6.5%Coherus BioSciences (NASDAQ:CHRS) Trading Up 6.5%
americanbankingnews.com - February 26 at 7:19 PM
Coherus BioSciences (NASDAQ:CHRS) Price Target Cut to $29.00Coherus BioSciences (NASDAQ:CHRS) Price Target Cut to $29.00
americanbankingnews.com - February 25 at 6:00 PM
Coherus BioSciences (NASDAQ:CHRS) Price Target Cut to $27.00Coherus BioSciences (NASDAQ:CHRS) Price Target Cut to $27.00
americanbankingnews.com - February 25 at 4:30 PM
Coherus Management to Present at Upcoming Investor ConferencesCoherus Management to Present at Upcoming Investor Conferences
finance.yahoo.com - February 25 at 1:13 PM
Coherus BioSciences (NASDAQ:CHRS) Releases  Earnings Results, Misses Expectations By $0.13 EPSCoherus BioSciences (NASDAQ:CHRS) Releases Earnings Results, Misses Expectations By $0.13 EPS
americanbankingnews.com - February 25 at 1:00 PM
Coherus BioSciences Inc (CHRS) Q4 2020 Earnings Call TranscriptCoherus BioSciences Inc (CHRS) Q4 2020 Earnings Call Transcript
finance.yahoo.com - February 25 at 1:46 AM
Coherus BioSciences (CHRS) Misses Q4 Earnings and Revenue EstimatesCoherus BioSciences (CHRS) Misses Q4 Earnings and Revenue Estimates
nasdaq.com - February 24 at 8:45 PM
Coherus BioSciences Reports Fourth Quarter and Full Year 2020 Financial ResultsCoherus BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results
finance.yahoo.com - February 24 at 8:45 PM
Coherus BioSciences (NASDAQ:CHRS)  Shares Down 5.2% Coherus BioSciences (NASDAQ:CHRS) Shares Down 5.2%
americanbankingnews.com - February 22 at 8:38 PM
Coherus BioSciences (CHRS) to Release Earnings on WednesdayCoherus BioSciences (CHRS) to Release Earnings on Wednesday
americanbankingnews.com - February 19 at 10:44 AM
Earnings Preview: Coherus BioSciences (CHRS) Q4 Earnings Expected to DeclineEarnings Preview: Coherus BioSciences (CHRS) Q4 Earnings Expected to Decline
nasdaq.com - February 19 at 9:23 AM
Coherus BioSciences to Report Fourth Quarter and Full Year 2020 Financial Results on February 24thCoherus BioSciences to Report Fourth Quarter and Full Year 2020 Financial Results on February 24th
finance.yahoo.com - February 18 at 8:39 AM
Coherus BLA Filing for Adalimumab Biosimilar Candidate Accepted by FDA for ReviewCoherus BLA Filing for Adalimumab Biosimilar Candidate Accepted by FDA for Review
finance.yahoo.com - February 17 at 9:08 AM
Coherus Announces CFO Transition PlansCoherus Announces CFO Transition Plans
finance.yahoo.com - February 16 at 8:49 AM
Did Coherus BioSciences (NASDAQ:CHRS) Share Price Deserve to Gain 89%?Did Coherus BioSciences' (NASDAQ:CHRS) Share Price Deserve to Gain 89%?
finance.yahoo.com - February 6 at 9:39 AM
Coherus BioSciences, Inc.: Coherus BioSciences to Receive $50 million Strategic Investment from Immuno-Oncology Partner Junshi BiosciencesCoherus BioSciences, Inc.: Coherus BioSciences to Receive $50 million Strategic Investment from Immuno-Oncology Partner Junshi Biosciences
finanznachrichten.de - February 2 at 9:16 AM
Coherus BioSciences to Receive $50 million Strategic Investment from Immuno-Oncology Partner Junshi BiosciencesCoherus BioSciences to Receive $50 million Strategic Investment from Immuno-Oncology Partner Junshi Biosciences
finance.yahoo.com - February 2 at 9:16 AM
Peninsula biosimilar maker switches gears with $150M deal for Chinese cancer-fighting drugPeninsula biosimilar maker switches gears with $150M deal for Chinese cancer-fighting drug
bizjournals.com - February 1 at 5:18 PM
CHRS Crosses Below Key Moving Average LevelCHRS Crosses Below Key Moving Average Level
nasdaq.com - February 1 at 5:18 PM
Coherus BioSciences to expand late-stage pipeline...Coherus BioSciences to expand late-stage pipeline...
benzinga.com - February 1 at 7:16 AM
Coherus BioSciences to expand late-stage pipeline to immuno-oncology with in-license of Junshi Biosciences’ PD-1, toripalimab, in United States and CanadaCoherus BioSciences to expand late-stage pipeline to immuno-oncology with in-license of Junshi Biosciences’ PD-1, toripalimab, in United States and Canada
finance.yahoo.com - February 1 at 7:16 AM
CHRS Feb 2021 15.000 putCHRS Feb 2021 15.000 put
au.finance.yahoo.com - January 21 at 5:25 PM
First Week of March 19th Options Trading For Coherus BioSciences (CHRS)First Week of March 19th Options Trading For Coherus BioSciences (CHRS)
nasdaq.com - January 15 at 9:48 PM
CHRS Crosses Above Key Moving Average LevelCHRS Crosses Above Key Moving Average Level
nasdaq.com - January 7 at 7:47 PM
Coherus BioSciences Management to Present at the 39th Annual J.P. Morgan Healthcare ConferenceCoherus BioSciences Management to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 5 at 8:25 PM
Coherus BioSciences, Inc. (CHRS) CEO Denny Lanfear on Q3 2020 Results - Earnings Call TranscriptCoherus BioSciences, Inc. (CHRS) CEO Denny Lanfear on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 8 at 2:06 PM
Coherus BioSciences, Inc. Earnings Missed Analyst Estimates: Heres What Analysts Are Forecasting NowCoherus BioSciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
nasdaq.com - November 7 at 12:54 PM
Earnings Miss: Coherus BioSciences, Inc. Missed EPS By 14% And Analysts Are Revising Their ForecastsEarnings Miss: Coherus BioSciences, Inc. Missed EPS By 14% And Analysts Are Revising Their Forecasts
finance.yahoo.com - November 7 at 12:54 PM
Coherus BioSciences EPS beats by $0.13, misses on revenue, revised FY20 outlookCoherus BioSciences EPS beats by $0.13, misses on revenue, revised FY20 outlook
seekingalpha.com - November 5 at 6:16 PM
Coherus BioSciences (CHRS) Lags Q3 Earnings and Revenue EstimatesCoherus BioSciences (CHRS) Lags Q3 Earnings and Revenue Estimates
msn.com - November 5 at 6:16 PM
Coherus BioSciences, Inc. to Host Earnings CallCoherus BioSciences, Inc. to Host Earnings Call
finance.yahoo.com - November 5 at 6:16 PM
Coherus BioSciences Reports Third Quarter 2020 Financial ResultsCoherus BioSciences Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 5 at 6:16 PM
Coherus BioSciences (CHRS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseCoherus BioSciences (CHRS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
finance.yahoo.com - October 29 at 2:21 PM
Whats in Store for Perrigo (PRGO) This Earnings Season?What's in Store for Perrigo (PRGO) This Earnings Season?
finance.yahoo.com - October 29 at 2:21 PM
CHRS or ILMN: Which Is the Better Value Stock Right Now?CHRS or ILMN: Which Is the Better Value Stock Right Now?
finance.yahoo.com - October 26 at 1:57 PM
Coherus BioSciences (CHRS) Moves to Buy: Rationale Behind the UpgradeCoherus BioSciences (CHRS) Moves to Buy: Rationale Behind the Upgrade
finance.yahoo.com - October 26 at 1:57 PM
Why Coherus BioSciences (CHRS) is Poised to Beat Earnings Estimates AgainWhy Coherus BioSciences (CHRS) is Poised to Beat Earnings Estimates Again
finance.yahoo.com - October 26 at 1:57 PM
Coherus BioSciences to Report Third Quarter Financial Results on November 5thCoherus BioSciences to Report Third Quarter Financial Results on November 5th
finance.yahoo.com - October 22 at 6:48 PM
Coherus Biosciences IncCoherus Biosciences Inc
reuters.com - September 22 at 11:41 PM
Coherus Has A High-Quality Business Model And Good Long-Term PotentialCoherus Has A High-Quality Business Model And Good Long-Term Potential
seekingalpha.com - September 13 at 12:27 PM
Our View On Coherus BioSciences (NASDAQ:CHRS) CEO PayOur View On Coherus BioSciences' (NASDAQ:CHRS) CEO Pay
finance.yahoo.com - September 13 at 12:27 PM
Our View On Coherus BioSciences' (NASDAQ:CHRS) CEO PayOur View On Coherus BioSciences' (NASDAQ:CHRS) CEO Pay
finance.yahoo.com - September 13 at 12:27 PM
Coherus BioSciences Keeps Proving Wall Street WrongCoherus BioSciences Keeps Proving Wall Street Wrong
finance.yahoo.com - August 19 at 3:42 AM
Coherus BioSciences (CHRS) CEO Denny Lanfear on Q2 2020 Results - Earnings Call TranscriptCoherus BioSciences' (CHRS) CEO Denny Lanfear on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 8:38 AM
Coherus BioSciences (CHRS) Q2 Earnings and Revenues Top EstimatesCoherus BioSciences (CHRS) Q2 Earnings and Revenues Top Estimates
finance.yahoo.com - August 7 at 1:40 AM
Coherus BioSciences EPS beats by $0.52, beats on revenueCoherus BioSciences EPS beats by $0.52, beats on revenue
seekingalpha.com - August 6 at 8:39 PM
Coherus BioSciences Reports Second Quarter 2020 Financial ResultsCoherus BioSciences Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 6 at 8:39 PM
This page was last updated on 3/7/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.